Therefore, the use of several non-steroidal anti-inflammatory active substances with antiproliferative activity and selective COX-2 inhibitors such as celecoxib and C-PC could be a logical approach to prevent or treat cancer based on various studies [33]. This evidence concerns the gene PTGS2 and cancer.